Abstract
This review deals with nitrogen oxides (NO, NO2, N2O) and NO derivatives peroxynitrite, peroxynitrous acid and nitroxyl, in relation to therapeutic effects and toxicity. An important member is NO which plays a multiple role in physiological action. The derivatives formed from interactions with superoxide are powerful oxidants functioning in toxicity. Nitroxyl (HNO), a metabolite of hydroxamic acids and hydroxyurea, is involved in the mode of action. Antioxidant action is discussed, as well as cell signaling. A multifaceted approach to bioaction is recommended.
Keywords: Nitrogen oxides (NO, NO2, N2O), peroxynitrite, hyponitrous acid, nitroxyl, mechanism, bioaction, Antioxidant action, cell signaling, Down’s syndrome, endothelial dysfunction
Current Bioactive Compounds
Title:Nitric Oxide, Peroxynitrite, Peroxynitrous Acid, Nitroxyl, Nitrogen Dioxide, Nitrous Oxide: Biochemical Mechanisms and Bioaction
Volume: 8 Issue: 4
Author(s): Peter Kovacic and Ratnasamy Somanathan
Affiliation:
Keywords: Nitrogen oxides (NO, NO2, N2O), peroxynitrite, hyponitrous acid, nitroxyl, mechanism, bioaction, Antioxidant action, cell signaling, Down’s syndrome, endothelial dysfunction
Abstract: This review deals with nitrogen oxides (NO, NO2, N2O) and NO derivatives peroxynitrite, peroxynitrous acid and nitroxyl, in relation to therapeutic effects and toxicity. An important member is NO which plays a multiple role in physiological action. The derivatives formed from interactions with superoxide are powerful oxidants functioning in toxicity. Nitroxyl (HNO), a metabolite of hydroxamic acids and hydroxyurea, is involved in the mode of action. Antioxidant action is discussed, as well as cell signaling. A multifaceted approach to bioaction is recommended.
Export Options
About this article
Cite this article as:
Kovacic Peter and Somanathan Ratnasamy, Nitric Oxide, Peroxynitrite, Peroxynitrous Acid, Nitroxyl, Nitrogen Dioxide, Nitrous Oxide: Biochemical Mechanisms and Bioaction, Current Bioactive Compounds 2012; 8 (4) . https://dx.doi.org/10.2174/1573407211208040001
DOI https://dx.doi.org/10.2174/1573407211208040001 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Regulation of Inflammation and Myocardial Fibrosis in Experimental Autoimmune Myocarditis
Inflammation & Allergy - Drug Targets (Discontinued) Cardiovascular Effects of Green Tea Catechins: Progress and Promise
Recent Patents on Cardiovascular Drug Discovery Obesity and Inflammation and Altered Clopidogrel Pharmacokinetics and Pharmacodynamics
Drug Metabolism Letters Arterial Stiffness, Cognitive Dysfunction and Adherence to Antihypertensive Agents. Is there a Link to Hypertensive Patients?
Current Vascular Pharmacology Combination of Statin Plus Renin Angiotensin System Inhibition for the Prevention or the Treatment of Atherosclerotic Cardiovascular Disease
Current Pharmaceutical Design Statins, Mevalonate Pathway and its Intermediate Products in Placental Development and Preeclampsia
Current Molecular Pharmacology Modulation of Inflammatory Response Improves Myocardial Infarct Healing in Rats
Current Pharmaceutical Design Screening of Novel Inhibitors Against Leishmania donovani Calcium ion Channel to Fight Leishmaniasis
Infectious Disorders - Drug Targets Prevention of Left Ventricular Remodelling after Acute Myocardial Infarction: An Update
Recent Patents on Cardiovascular Drug Discovery Understanding the Role of Aldose Reductase in Ocular Inflammation
Current Molecular Medicine QT Alterations in Psychopharmacology: Proven Candidates and Suspects
Current Drug Safety Drugs Targeting the Canonical NF-κB Pathway to Treat Viral and Autoimmune Myocarditis
Current Pharmaceutical Design Inflammation as the Common Biological Link Between Depression and Cardiovascular Diseases: Can Carnosine Exert a Protective Role?
Current Medicinal Chemistry Recent Advances in the Treatment of Neurogenic Erectile Dysfunction
Recent Patents on CNS Drug Discovery (Discontinued) Chronic Kidney Disease and the Search for New Biomarkers for Early Diagnosis
Current Medicinal Chemistry Induced Pluripotent Stem Cells as a Model for Accelerated Patient- and Disease-specific Drug Discovery
Current Medicinal Chemistry Update on Cardiovascular Effects of Older and Newer Anti-diabetic Medications
Current Medicinal Chemistry Dyslipidaemia Related to Insulin Resistance and Cardiovascular Disease in South Asian and West African Populations
Current Pharmaceutical Design Ghrelin in Obesity, Physiological and Pharmacological Considerations
Mini-Reviews in Medicinal Chemistry Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period
Recent Patents on Anti-Infective Drug Discovery